Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Candida albicans Infection

被引:0
|
作者
Singh, Gurmeet [1 ,2 ]
Narang, Raj Kumar [1 ,2 ]
机构
[1] IK Gujral Punjab Tech Univ, Dept Pharmaceut Sci, Kapurthala, Punjab, India
[2] ISF Coll Pharm, Dept Pharmaceut, GT Rd, Moga 142001, Punjab, India
关键词
luliconazole; transethosomes; Candida albicans; topical drug delivery; quality by design; Box-Behnken design; DELIVERY;
D O I
10.1089/adt.2023.059
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to develop and evaluate a novel vesicular formulation of luliconazole (LUL) for the management of Candida albicans infection through a topical route. LUL-loaded transethosomes (LUL-TE) were prepared by the film hydration method and various independent and dependent variables were optimized using the Box-Behnken design. Selected critical material attributes were the content of phospholipids (X1), concentration of ethanol (X2), and amount of sodium cholate (X3). Formulated LUL-TE were characterized for percent entrapment efficiency, percent drug loading, vesicle size, and polydispersity index (PDI) and were incorporated into the carbomer gel base and further evaluated for gel characterizations. The prepared transethosomal gel (LUL-TE-CHG) was evaluated for pH, spreadability, viscosity, antifungal activity, and in vitro study. From the observed results, it was evident that the prepared LUL-TE-CHG was in the desired pH (6.2 +/- 0.45), spreadability [8.3 +/- 0.42 g/(cm<middle dot>s)], viscosity (236.1-19.2.26 mPa<middle dot>s), nanovesicle size (252 +/- 9.82), entrapment efficiency (85% +/- 5.24%), zeta potential (-34.05 +/- 3.52 mV), and PDI (0.233 +/- 0.002). The zone of inhibition results suggested that the LUL-TE-CHG formulation has the highest antifungal activity, that is, 5.83 +/- 0.15 mm(3). The in vitro results showed that drug release within 2 h was 18.1% +/- 2.0% and after that sustained release action, 83.2% +/- 1.7% within 8 h. Finally, to confirm the therapeutic efficacy of the developed formulation, fungal infection was induced by using C. albicans in Wistar rats. In vivo, skin irritation study and histopathology studies were performed in the disease-induced model. Animal experiments revealed that LUL-TE-CHG has significantly improved the diseased condition in Wistar rats. The results observed from the skin permeation and skin deposition profile ensure that the prepared novel LUL-loaded TE system had a higher permeation rate and increased retention time compared with LUL-CHG. The hydrogel incorporated with LUL could be a novel approach with safe and effective fungal treatment.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 39 条
  • [31] Green Analytical Chemistry Based Quality by Design Assisted UV Spectroscopic Method Development and Validation for Estimation of Chrysin
    Karadesai, Manikant B.
    Patil, Akshay K.
    Mandi, Praneeth N.
    Jalalpure, Sunil S.
    ADVANCES IN PHARMACOLOGY AND PHARMACY, 2025, 13 (02) : 277 - 285
  • [32] Staged development of long-lived T-cell receptor αβ TH17 resident memory T-cell population to Candida albicans after skin infection
    Park, Chang Ook
    Fu, Xiujun
    Jiang, Xiaodong
    Pan, Youdong
    Teague, Jessica E.
    Collins, Nicholas
    Tian, Tian
    O'Malley, John T.
    Emerson, Ryan O.
    Kim, Ji Hye
    Jung, Yookyung
    Watanabe, Rei
    Fuhlbrigge, Robert C.
    Carbone, Francis R.
    Gebhardt, Thomas
    Clark, Rachael A.
    Lin, Charles P.
    Kupper, Thomas S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (02) : 647 - 662
  • [33] Design development and optimisation of multifunctional Doxorubicin-loaded Indocynanine Green proniosomal gel derived niosomes for tumour management
    Darson, Jaison
    Seshadri, Radha Thirunellai
    Katariya, Kajal
    Mohan, Mothilal
    Kamath, Manjunath Srinivas
    Etyala, Meher Abhinav
    Chandrasekaran, Gopalakrishnan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [34] A risk management ontology for Quality-by-Design based on a new development approach according GAMP 5.0
    Guebitz, Brigitte
    Schnedl, Hubert
    Khinast, Johannes G.
    EXPERT SYSTEMS WITH APPLICATIONS, 2012, 39 (08) : 7291 - 7301
  • [35] Quality by Design Guided Development of Polymeric Nanospheres of Terbinafine Hydrochloride for Topical Treatment of Onychomycosis Using a Nano-Gel Formulation
    Puri, Vinam
    Froelich, Anna
    Shah, Parinbhai
    Pringle, Shernelle
    Chen, Kevin
    Michniak-Kohn, Bozena
    PHARMACEUTICS, 2022, 14 (10)
  • [36] Enhancing Patient-Centric Drug Development: Coupling Hot Melt Extrusion with Fused Deposition Modeling and Pressure-Assisted Microsyringe Additive Manufacturing Platforms with Quality by Design
    Nyavanandi, Dinesh
    Mandati, Preethi
    Vidiyala, Nithin
    Parupathi, Prashanth
    Kolimi, Praveen
    Mamidi, Hemanth Kumar
    PHARMACEUTICS, 2025, 17 (01)
  • [37] Effect of Dental Caries Management on the Candida Albicans Carriage and Oral Health-Related Quality of Life in Children Living With Perinatal HIV/AIDS Under Antiretroviral Therapy-A Pre- and Post-Experimental Study
    Gurupriya, M. Monica
    Barathi, K. Divya
    Nalankilli, Ashok Viswanath
    Megalaa, N.
    Jayaraj, Merlin
    Kumar, P. D. Madan
    Nagappan, Nagappan
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2024, 16 (SUPPL 5) : S4445 - S4447
  • [38] Quality by design-assisted development of D-α-tocopherol polyethylene glycol 1000 succinate-incorporated gefitinib-loaded cationic liposome(s)
    Mishra, Lopamudra
    Bhowmik, Shuvadip
    Singh, Rajveer
    Patel, Preeti
    Gupta, Ghanshyam Das
    Kurmi, Balak Das
    THERAPEUTIC DELIVERY, 2023, 14 (12) : 745 - 761
  • [39] Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma
    Charankumar, Kondasingh
    Bagasariya, Deepkumar
    Jain, Naitik
    Famta, Paras
    Shah, Saurabh
    Vambhurkar, Ganesh
    Fernandes, Valencia
    Khatri, Dharmendra Kumar
    Singh, Shashi Bala
    Srivastava, Saurabh
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 84